Literature DB >> 20634385

Redeeming ristocetin.

J Evan Sadler1.   

Abstract

Entities:  

Year:  2010        PMID： 20634385     DOI： 10.1182/blood-2010-04-276394

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  A factor VIII-derived peptide enables von Willebrand factor (VWF)-binding of artificial platelet nanoconstructs without interfering with VWF-adhesion of natural platelets.

Authors:  Hassan Haji-Valizadeh; Christa L Modery-Pawlowski; Anirban Sen Gupta
Journal:  Nanoscale       Date:  2014-05-07       Impact factor: 7.790

2.  Rapid discrimination of the phenotypic variants of von Willebrand disease.

Authors:  Jonathan C Roberts; Patti A Morateck; Pamela A Christopherson; Ke Yan; Raymond G Hoffmann; Joan Cox Gill; Robert R Montgomery
Journal:  Blood       Date:  2016-02-25       Impact factor: 22.113

3.  A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.

Authors:  W Deng; Y Wang; S A Druzak; J F Healey; A K Syed; P Lollar; R Li
Journal:  J Thromb Haemost       Date:  2017-08-09       Impact factor: 5.824

4.  The physical spacing between the von Willebrand factor D'D3 and A1 domains regulates platelet adhesion in vitro and in vivo.

Authors:  C Zhang; A Kelkar; M Nasirikenari; J T Y Lau; M Sveinsson; U C Sharma; S Pokharel; S Neelamegham
Journal:  J Thromb Haemost       Date:  2018-01-22       Impact factor: 5.824

5.  No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.

Authors:  Veronica H Flood; Kenneth D Friedman; Joan Cox Gill; Sandra L Haberichter; Pamela A Christopherson; Brian R Branchford; Raymond G Hoffmann; Thomas C Abshire; Amy L Dunn; Jorge A Di Paola; W Keith Hoots; Deborah L Brown; Cindy Leissinger; Jeanne M Lusher; Margaret V Ragni; Amy D Shapiro; Robert R Montgomery
Journal:  Blood       Date:  2013-03-21       Impact factor: 22.113

6.  Platelet GpIba binding to von Willebrand Factor under fluid shear:contributions of the D′D3-domain, A1-domain flanking peptide and O-linked glycans.

Authors:  Sri R Madabhushi; Changjie Zhang; Anju Kelkar; Kannayakanahalli M Dayananda; Sriram Neelamegham
Journal:  J Am Heart Assoc       Date:  2014-10-23       Impact factor: 5.501
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.